메뉴 건너뛰기




Volumn 43, Issue 6, 2013, Pages 1809-1816

Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells

Author keywords

ATRA; CDI38; Hypoxic; Myeloma

Indexed keywords

ALDEHYDE DEHYDROGENASE; BORTEZOMIB; CD20 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; MEMBRANE ANTIGEN; RETINOIC ACID; SUPPRESSOR OF CYTOKINE SIGNALING 1; SYNDECAN 1; TRANSCRIPTION FACTOR;

EID: 84891928973     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2134     Document Type: Article
Times cited : (44)

References (45)
  • 1
    • 41949130070 scopus 로고    scopus 로고
    • Improved survival in multiple myeloma and the impact of novel therapies
    • Kumar SK, Rajkumar SV, Dispenzieri A, et al: Improved survival in multiple myeloma and the impact of novel therapies. Blood 111: 2516-2520, 2008.
    • (2008) Blood , vol.111 , pp. 2516-2520
    • Kumar, S.K.1    Rajkumar, S.V.2    Dispenzieri, A.3
  • 2
    • 33750313208 scopus 로고    scopus 로고
    • Cancer stem cells - Perspectives on current status and future directions: AACR Workshop on cancer stem cells
    • Clarke MF, Dick JE, Dirks PB, et al: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344, 2006.
    • (2006) Cancer Res , vol.66 , pp. 9339-9344
    • Clarke, M.F.1    Dick, J.E.2    Dirks, P.B.3
  • 3
    • 1542283717 scopus 로고    scopus 로고
    • Characterization of clonogenic multiple myeloma cells
    • Matsui W, Huff CA, Wang Q, et al: Characterization of clonogenic multiple myeloma cells. Blood 103: 2332-2336, 2004.
    • (2004) Blood , vol.103 , pp. 2332-2336
    • Matsui, W.1    Huff, C.A.2    Wang, Q.3
  • 4
    • 0037085786 scopus 로고    scopus 로고
    • The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression
    • Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I and Brieva JA: The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99: 2154-2161, 2002.
    • (2002) Blood , vol.99 , pp. 2154-2161
    • Medina, F.1    Segundo, C.2    Campos-Caro, A.3    Gonzalez-Garcia, I.4    Brieva, J.A.5
  • 5
    • 8944235348 scopus 로고    scopus 로고
    • A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1
    • Wijdenes J, Vooijs WC, Clement C, et al: A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 94: 318-323, 1996.
    • (1996) Br J Haematol , vol.94 , pp. 318-323
    • Wijdenes, J.1    Vooijs, W.C.2    Clement, C.3
  • 6
    • 67449119398 scopus 로고    scopus 로고
    • The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo
    • Ikeda H, Hideshima T, Fulciniti M, et al: The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo. Clin Cancer Res 15: 4028-4037, 2009.
    • (2009) Clin Cancer Res , vol.15 , pp. 4028-4037
    • Ikeda, H.1    Hideshima, T.2    Fulciniti, M.3
  • 7
    • 0031711326 scopus 로고    scopus 로고
    • Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia
    • Witzig TE, Kimlinger T, Stenson M and Therneau T: Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leuk Lymphoma 31: 167-175, 1998.
    • (1998) Leuk Lymphoma , vol.31 , pp. 167-175
    • Witzig, T.E.1    Kimlinger, T.2    Stenson, M.3    Therneau, T.4
  • 8
    • 78349284733 scopus 로고    scopus 로고
    • Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma
    • Reid S, Yang S, Brown R, et al: Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma. Int J Lab Hematol 32: e190-e196, 2010.
    • (2010) Int J Lab Hematol , vol.32
    • Reid, S.1    Yang, S.2    Brown, R.3
  • 9
    • 84865011312 scopus 로고    scopus 로고
    • Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
    • Kawano Y, Fujiwara S, Wada N, et al: Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. Int J Oncol 41: 876-884, 2012.
    • (2012) Int J Oncol , vol.41 , pp. 876-884
    • Kawano, Y.1    Fujiwara, S.2    Wada, N.3
  • 10
    • 79955974540 scopus 로고    scopus 로고
    • Lenalidomide targets clonogenic side population in multiple myeloma: Pathophysiologic and clinical implications
    • Jakubikova J, Adamia S, Kost-Alimova M, et al: Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood 117: 4409-4419, 2011.
    • (2011) Blood , vol.117 , pp. 4409-4419
    • Jakubikova, J.1    Adamia, S.2    Kost-Alimova, M.3
  • 11
    • 84859905863 scopus 로고    scopus 로고
    • Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model
    • Van Valckenborgh E, Matsui W, Agarwal P, et al: Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model. Leukemia 26: 1436-1439, 2012.
    • (2012) Leukemia , vol.26 , pp. 1436-1439
    • Van Valckenborgh, E.1    Matsui, W.2    Agarwal, P.3
  • 12
    • 84872345792 scopus 로고    scopus 로고
    • Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
    • Chaidos A, Barnes CP, Cowan G, et al: Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma. Blood 121: 318-328, 2013.
    • (2013) Blood , vol.121 , pp. 318-328
    • Chaidos, A.1    Barnes, C.P.2    Cowan, G.3
  • 13
    • 27744526844 scopus 로고    scopus 로고
    • The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype
    • Yaccoby S: The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype. Clin Cancer Res 11: 7599-7606, 2005.
    • (2005) Clin Cancer Res , vol.11 , pp. 7599-7606
    • Yaccoby, S.1
  • 15
    • 67349092202 scopus 로고    scopus 로고
    • Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6
    • Dezorella N, Pevsner-Fischer M, Deutsch V, et al: Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6. Exp Cell Res 315: 1904-1913, 2009.
    • (2009) Exp Cell Res , vol.315 , pp. 1904-1913
    • Dezorella, N.1    Pevsner-Fischer, M.2    Deutsch, V.3
  • 16
    • 77953229444 scopus 로고    scopus 로고
    • Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells
    • Fuhler GM, Baanstra M, Chesik D, et al: Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells. Exp Cell Res 316: 1816-1828, 2010.
    • (2010) Exp Cell Res , vol.316 , pp. 1816-1828
    • Fuhler, G.M.1    Baanstra, M.2    Chesik, D.3
  • 17
    • 24344440832 scopus 로고    scopus 로고
    • Hypoxia-induced dedifferentiation of tumor cells - A mechanism behind heterogeneity and aggressiveness of solid tumors
    • Axelson H, Fredlund E, Ovenberger M, Landberg G and Pahlman S: Hypoxia-induced dedifferentiation of tumor cells - a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 16: 554-563, 2005.
    • (2005) Semin Cell Dev Biol , vol.16 , pp. 554-563
    • Axelson, H.1    Fredlund, E.2    Ovenberger, M.3    Landberg, G.4    Pahlman, S.5
  • 18
    • 84862506605 scopus 로고    scopus 로고
    • Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
    • Azab AK, Hu J, Quang P, et al: Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features. Blood 119: 5782-5794, 2012
    • (2012) Blood , vol.119 , pp. 5782-5794
    • Azab, A.K.1    Hu, J.2    Quang, P.3
  • 19
    • 0024359185 scopus 로고
    • Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32)
    • Ohtsuki T, Yawata Y, Wada H, Sugihara T, Mori M and Namba M: Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). Br J Haematol 73: 199-204, 1989.
    • (1989) Br J Haematol , vol.73 , pp. 199-204
    • Ohtsuki, T.1    Yawata, Y.2    Wada, H.3    Sugihara, T.4    Mori, M.5    Namba, M.6
  • 20
    • 0014115428 scopus 로고
    • Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma
    • Matsuoka Y, Moore GE, Yagi Y and Pressman D: Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med 125: 1246-1250, 1967.
    • (1967) Proc Soc Exp Biol Med , vol.125 , pp. 1246-1250
    • Matsuoka, Y.1    Moore, G.E.2    Yagi, Y.3    Pressman, D.4
  • 21
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
    • Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
    • (2001) Methods , vol.25 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 22
    • 84872548105 scopus 로고    scopus 로고
    • PDK1 inhibition is a novel therapeutic target in multiple myeloma
    • Fujiwara S, Kawano Y, Yuki H, et al: PDK1 inhibition is a novel therapeutic target in multiple myeloma. Br J Cancer 108: 170-178, 2013.
    • (2013) Br J Cancer , vol.108 , pp. 170-178
    • Fujiwara, S.1    Kawano, Y.2    Yuki, H.3
  • 23
    • 0031929051 scopus 로고    scopus 로고
    • The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells
    • Jourdan M, Ferlin M, Legouffe E, et al: The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells. Br J Haematol 100: 637-646, 1998.
    • (1998) Br J Haematol , vol.100 , pp. 637-646
    • Jourdan, M.1    Ferlin, M.2    Legouffe, E.3
  • 24
    • 0027500204 scopus 로고
    • Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen
    • Ridley RC, Xiao H, Hata H, Woodliff J, Epstein J and Sanderson RD: Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81: 767-774, 1993.
    • (1993) Blood , vol.81 , pp. 767-774
    • Ridley, R.C.1    Xiao, H.2    Hata, H.3    Woodliff, J.4    Epstein, J.5    Sanderson, R.D.6
  • 25
    • 47049120726 scopus 로고    scopus 로고
    • IRF4 addiction in multiple myeloma
    • Shaffer AL, Emre NC, Lamy L, et al: IRF4 addiction in multiple myeloma. Nature 454: 226-231, 2008.
    • (2008) Nature , vol.454 , pp. 226-231
    • Shaffer, A.L.1    Emre, N.C.2    Lamy, L.3
  • 26
    • 14944362858 scopus 로고    scopus 로고
    • Regulation of plasma-cell development
    • Shapiro-Shelef M and Calame K: Regulation of plasma-cell development. Nat Rev Immunol 5: 230-242, 2005.
    • (2005) Nat Rev Immunol , vol.5 , pp. 230-242
    • Shapiro-Shelef, M.1    Calame, K.2
  • 27
    • 34247527730 scopus 로고    scopus 로고
    • Hypoxia-inducible factors, stem cells, and cancer
    • Keith B and Simon MC: Hypoxia-inducible factors, stem cells, and cancer. Cell 129: 465-472, 2007.
    • (2007) Cell , vol.129 , pp. 465-472
    • Keith, B.1    Simon, M.C.2
  • 28
    • 79959908506 scopus 로고    scopus 로고
    • HIF induces human embryonic stem cell markers in cancer cells
    • Mathieu J, Zhang Z, Zhou W, et al: HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 71: 4640-4652, 2011.
    • (2011) Cancer Res , vol.71 , pp. 4640-4652
    • Mathieu, J.1    Zhang, Z.2    Zhou, W.3
  • 29
    • 77958584577 scopus 로고    scopus 로고
    • Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms
    • Brennan SK, Wang Q, Tressler R, et al: Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms. PLoS One 5: 2010.
    • (2010) PLoS One , vol.5
    • Brennan, S.K.1    Wang, Q.2    Tressler, R.3
  • 30
    • 0034795256 scopus 로고    scopus 로고
    • The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
    • Zhou S, Schuetz JD, Bunting KD, et al: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028-1034, 2001.
    • (2001) Nat Med , vol.7 , pp. 1028-1034
    • Zhou, S.1    Schuetz, J.D.2    Bunting, K.D.3
  • 31
    • 78649646015 scopus 로고    scopus 로고
    • Retinoids regulate stem cell differentiation
    • Gudas LJ and Wagner JA: Retinoids regulate stem cell differentiation. J Cell Physiol 226: 322-330, 2011.
    • (2011) J Cell Physiol , vol.226 , pp. 322-330
    • Gudas, L.J.1    Wagner, J.A.2
  • 32
    • 68849097535 scopus 로고    scopus 로고
    • All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells
    • Huang H, Wu D, Fu J, et al: All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells. Eur J Haematol 83: 191-202, 2009.
    • (2009) Eur J Haematol , vol.83 , pp. 191-202
    • Huang, H.1    Wu, D.2    Fu, J.3
  • 33
    • 84859625301 scopus 로고    scopus 로고
    • Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma
    • Gu JL, Li J, Zhou ZH, et al: Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma. Biochem Biophys Res Commun 420: 644-650, 2012.
    • (2012) Biochem Biophys Res Commun , vol.420 , pp. 644-650
    • Gu, J.L.1    Li, J.2    Zhou, Z.H.3
  • 34
    • 60849117802 scopus 로고    scopus 로고
    • Suppression of Oct4 by germ cell nuclear factor restricts pluripotency and promotes neural stem cell development in the early neural lineage
    • Akamatsu W, DeVeale B, Okano H, Cooney AJ and van der Kooy D: Suppression of Oct4 by germ cell nuclear factor restricts pluripotency and promotes neural stem cell development in the early neural lineage. J Neurosci 29: 2113-2124, 2009.
    • (2009) J Neurosci , vol.29 , pp. 2113-2124
    • Akamatsu, W.1    DeVeale, B.2    Okano, H.3    Cooney, A.J.4    Van Der Kooy, D.5
  • 35
    • 25444473355 scopus 로고    scopus 로고
    • Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation
    • Gu P, LeMenuet D, Chung AC, Mancini M, Wheeler DA and Cooney AJ: Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol 25: 8507-8519, 2005.
    • (2005) Mol Cell Biol , vol.25 , pp. 8507-8519
    • Gu, P.1    LeMenuet, D.2    Chung, A.C.3    Mancini, M.4    Wheeler, D.A.5    Cooney, A.J.6
  • 36
    • 84865862858 scopus 로고    scopus 로고
    • CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients
    • Hosen N, Matsuoka Y, Kishida S, et al: CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. Leukemia 26: 2135-2141, 2012.
    • (2012) Leukemia , vol.26 , pp. 2135-2141
    • Hosen, N.1    Matsuoka, Y.2    Kishida, S.3
  • 37
    • 0030720094 scopus 로고    scopus 로고
    • Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential
    • Matsumoto A, Ono M, Fujimoto Y, Gallo RL, Bernfield M and Kohgo Y: Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer 74: 482-491, 1997.
    • (1997) Int J Cancer , vol.74 , pp. 482-491
    • Matsumoto, A.1    Ono, M.2    Fujimoto, Y.3    Gallo, R.L.4    Bernfield, M.5    Kohgo, Y.6
  • 38
    • 77649187760 scopus 로고    scopus 로고
    • Sdc1 negatively modulates carcinoma cell motility and invasion
    • Ishikawa T and Kramer RH: Sdc1 negatively modulates carcinoma cell motility and invasion. Exp Cell Res 316: 951-965, 2010.
    • (2010) Exp Cell Res , vol.316 , pp. 951-965
    • Ishikawa, T.1    Kramer, R.H.2
  • 39
    • 77950559481 scopus 로고    scopus 로고
    • Heparanaseenhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
    • Purushothaman A, Uyama T, Kobayashi F, et al: Heparanaseenhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 115: 2449-2457, 2010.
    • (2010) Blood , vol.115 , pp. 2449-2457
    • Purushothaman, A.1    Uyama, T.2    Kobayashi, F.3
  • 40
    • 0027316197 scopus 로고
    • Phenotypic difference of normal plasma cells from mature myeloma cells
    • Harada H, Kawano MM, Huang N, et al: Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 81: 2658-2663, 1993.
    • (1993) Blood , vol.81 , pp. 2658-2663
    • Harada, H.1    Kawano, M.M.2    Huang, N.3
  • 41
    • 77955795745 scopus 로고    scopus 로고
    • Hypoxia and activated VEGF/receptor pathway in multiple myeloma
    • Giatromanolaki A, Bai M, Margaritis D, et al: Hypoxia and activated VEGF/receptor pathway in multiple myeloma. Anticancer Res 30: 2831-2836, 2010.
    • (2010) Anticancer Res , vol.30 , pp. 2831-2836
    • Giatromanolaki, A.1    Bai, M.2    Margaritis, D.3
  • 42
    • 77952314832 scopus 로고    scopus 로고
    • Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells
    • Martin SK, Diamond P, Williams SA, et al: Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells. Haematologica 95: 776-784, 2010.
    • (2010) Haematologica , vol.95 , pp. 776-784
    • Martin, S.K.1    Diamond, P.2    Williams, S.A.3
  • 43
    • 34247339604 scopus 로고    scopus 로고
    • Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
    • Spisek R, Kukreja A, Chen LC, et al: Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. J Exp Med 204: 831-840, 2007.
    • (2007) J Exp Med , vol.204 , pp. 831-840
    • Spisek, R.1    Kukreja, A.2    Chen, L.C.3
  • 44
    • 84865860989 scopus 로고    scopus 로고
    • Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors
    • Ikegame A, Ozaki S, Tsuji D, et al: Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency- associated transcription factors. Leukemia 26: 2124-2134, 2012.
    • (2012) Leukemia , vol.26 , pp. 2124-2134
    • Ikegame, A.1    Ozaki, S.2    Tsuji, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.